143 results
8-K
EX-99.1
vahjji3x6wvf 3jv2u9v
2 May 24
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
7:31am
424B5
q56xekqsfj2n3rga2
6 Mar 24
Prospectus supplement for primary offering
5:15pm
8-K
EX-1.1
vzld2j2be95m5mu13
6 Mar 24
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
5:13pm
8-K
EX-99.1
ljvhv4b
6 Mar 24
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
5:13pm
424B5
o465n2dign 7h6w
4 Mar 24
Prospectus supplement for primary offering
5:25pm
8-K
EX-99.1
v5naebbx73e3zvfvtug
22 Feb 24
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
7:31am
8-K
EX-99.1
0kl9wno
2 Nov 23
BridgeBio Pharma Reports Third Quarter 2023 Financial Results and Business Update
7:31am
8-K
EX-10.1
dagnqy utfivs
25 Sep 23
BridgeBio Pharma Announces $250 Million Private Placement Equity Financing
4:00pm